BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26341006)

  • 1. Continuous culture of Cryptosporidium parvum using hollow fiber technology.
    Morada M; Lee S; Gunther-Cummins L; Weiss LM; Widmer G; Tzipori S; Yarlett N
    Int J Parasitol; 2016 Jan; 46(1):21-9. PubMed ID: 26341006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice.
    Yang S; Healey MC; Du C
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of amplification method for Cryptosporidium parvum oocysts from mice].
    Huang KH; Yang SG; Tang JX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(6):360-2. PubMed ID: 12572074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts.
    Yang S; Healey MC
    J Parasitol; 1994 Apr; 80(2):338-42. PubMed ID: 8158484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts.
    Petry F; Robinson HA; McDonald V
    J Clin Microbiol; 1995 Jul; 33(7):1922-4. PubMed ID: 7665672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blind trials evaluating in vitro infectivity of Cryptosporidium oocysts using cell culture immunofluorescence.
    Bukhari Z; Holt DM; Ware MW; Schaefer FW
    Can J Microbiol; 2007 May; 53(5):656-63. PubMed ID: 17668024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum.
    Yang S; Benson SK; Du C; Healey MC
    J Parasitol; 2000 Aug; 86(4):884-7. PubMed ID: 10958482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
    Zhang X; Kim CY; Worthen T; Witola WH
    Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and virulence analysis of in vitro cultured Cryptosporidium parvum.
    Yarlett N; Morada M; Schaefer DA; Ackman K; Carranza E; Baptista RP; Riggs MW; Kissinger JC
    PLoS Pathog; 2024 Feb; 20(2):e1011992. PubMed ID: 38416794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Culture of Cryptosporidium parvum Using Hollow Fiber Bioreactor: Applications for Simultaneous Pharmacokinetic and Pharmacodynamic Evaluation of Test Compounds.
    Yarlett N; Morada M; Gobin M; Van Voorhis W; Arnold S
    Methods Mol Biol; 2020; 2052():335-350. PubMed ID: 31452171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of infectious Cryptosporidium oocysts by cell culture immunofluorescence assay: applicability to environmental samples.
    Schets FM; Engels GB; During M; de Roda Husman AM
    Appl Environ Microbiol; 2005 Nov; 71(11):6793-8. PubMed ID: 16269711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of differences between DNA content of cell-cultured and freely suspended oocysts of Cryptosporidium parvum and their suitability as DNA standards in qPCR.
    Woolsey ID; Blomstrand B; Øines Ø; Enemark HL
    Parasit Vectors; 2019 Dec; 12(1):596. PubMed ID: 31856894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The infectivity of Cryptosporidium parvum in healthy volunteers.
    DuPont HL; Chappell CL; Sterling CR; Okhuysen PC; Rose JB; Jakubowski W
    N Engl J Med; 1995 Mar; 332(13):855-9. PubMed ID: 7870140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryopreservation of infectious Cryptosporidium parvum oocysts.
    Jaskiewicz JJ; Sandlin RD; Swei AA; Widmer G; Toner M; Tzipori S
    Nat Commun; 2018 Jul; 9(1):2883. PubMed ID: 30038430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cryptosporidium parvum (Apicomplexa: Sporozoa, Coccidia)--the optimization of a technic for isolating a large number of oocysts].
    Beĭer TV; Sidorenko NV; Grigor'ev MV
    Parazitologiia; 1995; 29(3):198-207. PubMed ID: 7567079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of temperature on Cryptosporidium parvum oocyst infectivity in river water samples as detected by tissue culture assay.
    Pokorny NJ; Weir SC; Carreno RA; Trevors JT; Lee H
    J Parasitol; 2002 Jun; 88(3):641-3. PubMed ID: 12099446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.